ADMS - Adamas Pharmaceuticals Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS) Q2 2021 Earnings Conference Call August 09, 2021, 04:30 PM ET Company Participants Peter Vozzo - Investor Relations Neil McFarlane - Chief Executive Officer Vijay Shreedhar - Chief Commercial Officer Chris Prentiss - Chief Financial Officer Adrian Quartel - Chief Medical Officer Conference Call Participants Jason Butler - JMP Securities Ken Cacciatore - Cowen Marc Goodman - SVB Leerink David Amsellem - Piper Sandler Presentation Operator Greetings and welcome to the Adamas Pharmaceuticals Second Quarter 2021 Financial Results and Corporate Update Conference Call. At this time all participates are in a listen-only mode. [Operator Instructions] I would now like to turn the call over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead sir. Peter Vozzo Thank you, Michelle, and good afternoon, everyone. On the call with me today are Neil McFarlane, Chief Executive Officer; Vijay Shreedhar, Chief Commercial Officer; and Chris Prentiss,
For further details see:
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results - Earnings Call Transcript